Clinical Trials Directory

Trials / Completed

CompletedNCT03875417

Multidisciplinary Management of HCC in Elderly Patients

Multidisciplinary HCC Treatment in Elderly : QoL and Survival Analysis

Status
Completed
Phase
Study type
Observational
Enrollment
126 (actual)
Sponsor
Azienda Policlinico Umberto I · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

Aim of this study is to evaluate whether treating HCC recurrences in resected elderly patients is advantageous or not.

Detailed description

Introduction- Hepatocellular carcinoma (HCC) is the most common primary liver malignancy. It usually develops in cirrhotic liver with high recurrence rates. More than 2/3 of patients are elderly, often excluded from surgery and follow-up protocols. Aim of this study is to evaluate whether treating HCC recurrences in resected elderly patients is advantageous or not. Materials and methods- 126 patients, aged between 65 and 90 years, submitted to liver resection for HCC were enrolled. They were divided into three classes. Class 1 included patients submitted to major resections, Class 2 to minor resections and Class 3 to minor resections associated with thermoablation. All of them were clinically and radiologically followed up. Patients who developed recurrences (Group A) were referred to further treatments (surgery, interventional radiology or pharmacological therapy). Mortality, disease-free survival (DFS), overall survival (OS) and quality of life (QoL) were evaluated and compared with non-recurrent patients (Group B). Used interventional radiology means were Radiofrequency ablation (RF), microwaves ablation (MWA) or transcatheter arterial chemoembolization (TACE).

Conditions

Interventions

TypeNameDescription
PROCEDUREliver resectionresection of one or more HCC nodules within the liver
PROCEDUREThermic ablationablation of HCC nodule through a percutaneous needle, by using radiofrequency or microwaves
PROCEDURETranscatheter arterial chemoembolizationembolization of HCC nodule via drug-eluted microbeads.

Timeline

Start date
2018-01-01
Primary completion
2018-05-30
Completion
2018-10-31
First posted
2019-03-14
Last updated
2019-03-14

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT03875417. Inclusion in this directory is not an endorsement.